ACROBiosystems is providing you with a series of recombinant cytokines and their receptors ... helping accelerate your autoimmune diseases drug development programs. Never miss a story ...

In the realm of medicine, recombinant cytokines are increasingly being utilized as therapeutic agents for a variety of diseases, including cancers, infections, and hematopoietic disorders. These ...

Such systems have been developed to reduce uncertainty and variability in the manufacturing process, thereby ensuring high quality of cytokine products. Unlike recombinant drugs, GMP-grade ...

Cytokines are extensively utilized ... for high-throughput and large-scale production of antibody drugs. The platform provides recombinant antibody production services in the milligram to kilogram ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...

it was time to bring the recombinant insulin to the market. In 1982 Food and Drug Administration approved Humulin, Eli Lily’s recombinant insulin made from Genentech’s specially modified bacteria. It ...

The drug candidates comprise modified versions of recombinant human interleukin ... “IL-18 is a key cytokine that, when combined synergistically with IL-12, has the potential to be an important ...

Be part of the only industry focused event exclusively addressing discovery, translational and reverse translational challenges for Cytokine-Based drug developers. View the full program and ...

The Swiss drug development ... is a recombinant, fully human monoclonal antibody with long-acting properties that can potentially be dosed every six months. WIN378 targets ligand of thymic stromal ...